Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 12.88% |
$462,465
$43.02 p/Share
|
Jan 04
2021 |
|
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,570 Reduced 6.24% |
$67,573
$43.04 p/Share
|
Jan 04
2021 |
|
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 19,000 Reduced 100.0% |
$1,075,970
$56.63 p/Share
|
Jan 04
2021 |
|
IGMS
|
Bruce Keyt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect | 883 Reduced 46.57% |
$77,766
$88.07 p/Share
|
Jan 04
2021 |
|
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,083 Reduced 0.53% |
$44,222
$21.23 p/Share
|
Jan 04
2021 |
|
SRDX
|
Gary R Maharaj
President & CEO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.36% |
$87,920
$43.96 p/Share
|
Jan 04
2021 |
|
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 99.44% |
$337,782
$59.26 p/Share
|
Jan 04
2021 |
|
CPSI
|
John B Douglas Jr |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.09% |
$5,400
$27.0 p/Share
|
Jan 04
2021 |
|
ABML
|
John Hunter William
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.18% |
$28,000
$1.4 p/Share
|
Jan 04
2021 |
|
WKHS
|
Duane Hughes
CEO and President |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 6.88% |
$518,250
$20.73 p/Share
|
Jan 04
2021 |
|
WKHS
|
H. Benjamin Samuels
Director |
SELL
Open market or private sale
|
Direct | 33,333 Reduced 5.95% |
$690,993
$20.73 p/Share
|
Jan 04
2021 |
|
WKHS
|
H. Benjamin Samuels
Director |
SELL
Open market or private sale
|
Indirect | 66,666 Reduced 7.02% |
$1,381,986
$20.73 p/Share
|
Jan 04
2021 |
|
AKRO
|
Jonathan Young
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,060 Reduced 1.66% |
$78,458
$25.64 p/Share
|
Jan 04
2021 |
|
MGTX
|
Stuart Naylor
CHIEF DEV. OFFICER |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 1.33% |
$92,400
$15.4 p/Share
|
Jan 04
2021 |
|
MRSN
|
Ashish Mandelia
VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 247 Reduced 100.0% |
$6,610
$26.76 p/Share
|
Jan 04
2021 |
|
PRTHW
|
Sean Kiewiet
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.5% |
$63,100
$6.31 p/Share
|
Jan 04
2021 |
|
KALV
|
Thomas Andrew Crockett
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.12% |
$184,900
$18.49 p/Share
|
Jan 04
2021 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.55% |
$113,663
$90.93 p/Share
|
Jan 04
2021 |
|
TCMD
|
William W Burke
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 20.43% |
$67,695
$45.13 p/Share
|
Jan 04
2021 |
|
PBYI
|
Alan H Auerbach
President and CEO |
SELL
Open market or private sale
|
Direct | 18,235 Reduced 0.42% |
$186,362
$10.22 p/Share
|
Jan 04
2021 |
|
PBYI
|
Maximo F Nougues
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,145 Reduced 13.79% |
$21,922
$10.22 p/Share
|
Jan 04
2021 |
|
PBYI
|
Douglas M Hunt
Officer |
SELL
Open market or private sale
|
Direct | 6,463 Reduced 11.39% |
$66,116
$10.23 p/Share
|
Jan 04
2021 |
|
PBYI
|
Richard Paul Bryce
Officer |
SELL
Open market or private sale
|
Direct | 6,548 Reduced 8.55% |
$66,986
$10.23 p/Share
|
Jan 04
2021 |
|
FIXX
|
Timothy P Kelly
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 100.0% |
$46,000
$11.5 p/Share
|
Jan 04
2021 |
|
BDTX
|
Christopher D. Roberts
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 43.86% |
$78,875
$31.55 p/Share
|
Jan 04
2021 |
|
BDTX
|
David M. Epstein |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 1.69% |
$376,800
$31.4 p/Share
|
Jan 04
2021 |
|
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,888 Reduced 0.16% |
$30,029
$5.1 p/Share
|
Jan 04
2021 |
|
TRHC
|
Andrea Carolan Speers
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,301 Reduced 15.96% |
$221,741
$41.83 p/Share
|
Jan 04
2021 |
|
TRHC
|
Michael Greenhalgh
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 2,568 Reduced 1.78% |
$107,240
$41.76 p/Share
|
Jan 04
2021 |
|
TRHC
|
Brian W Adams
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 6,160 Reduced 2.81% |
$257,242
$41.76 p/Share
|
Jan 04
2021 |
|
CFMS
|
Mark A Augusti
FORMER PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 61,025 Reduced 2.61% |
$39,056
$0.64 p/Share
|
Jan 04
2021 |
|
HARP
|
Holger Wesche
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.91% |
$183,400
$18.34 p/Share
|
Jan 04
2021 |
|
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 34,104 Reduced 9.97% |
$1,161,241
$34.05 p/Share
|
Jan 04
2021 |
|
AAOI
|
Stefan J. Murry
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 3.25% |
$26,010
$8.67 p/Share
|
Jan 04
2021 |
|
EGIO
|
Robert A Lento
CEO |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 1.07% |
$87,499
$4.2 p/Share
|
Jan 04
2021 |
|
TCRT
|
Eleanor De Groot
EVP, Operations |
SELL
Open market or private sale
|
Direct | 21,620 Reduced 9.48% |
$58,806
$2.72 p/Share
|
Jan 04
2021 |
|
TCRT
|
Laurence James Neil Cooper
President and CEO |
SELL
Open market or private sale
|
Direct | 105,693 Reduced 5.55% |
$286,428
$2.71 p/Share
|
Jan 04
2021 |
|
XLRN
|
Sujay Kango
EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 71.49% |
$1,250,700
$125.07 p/Share
|
Jan 04
2021 |
|
XLRN
|
Kevin F Mclaughlin
SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 3,280 Reduced 30.97% |
$407,671
$124.29 p/Share
|
Jan 04
2021 |
|
WORK
|
Brandon Zell
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,378 Reduced 2.46% |
$183,832
$41.99 p/Share
|
Jan 04
2021 |
|
WORK
|
Robert Frati
Sr VP Sales, Customer Success |
SELL
Open market or private sale
|
Direct | 2,155 Reduced 0.73% |
$90,488
$41.99 p/Share
|
Jan 04
2021 |
|
WORK
|
David Schellhase
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 1,679 Reduced 0.52% |
$70,501
$41.99 p/Share
|
Jan 04
2021 |
|
WORK
|
Allen Shim
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,557 Reduced 0.71% |
$65,378
$41.99 p/Share
|
Jan 04
2021 |
|
WORK
|
Graham Smith
Director |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 20.07% |
$338,240
$42.28 p/Share
|
Jan 04
2021 |
|
WORK
|
Cal Henderson
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,252 Reduced 2.98% |
$52,571
$41.99 p/Share
|
Jan 04
2021 |
|
WORK
|
Tamar Yehoshua
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 49,288 Reduced 28.5% |
$2,069,603
$41.99 p/Share
|
Jan 04
2021 |
|
EXAS
|
Kevin T Conroy
President and CEO |
SELL
Open market or private sale
|
Direct | 31,814 Reduced 3.71% |
$4,095,735
$128.74 p/Share
|
Jan 04
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$866,550
$57.77 p/Share
|
Jan 04
2021 |
|
MLSS
|
Joseph D'Agostino
CFO & COO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.86% |
$44,000
$2.2 p/Share
|
Jan 04
2021 |
|
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Indirect | 532 Reduced 0.02% |
$8,113
$15.25 p/Share
|
Jan 04
2021 |